| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 02/15/2007 | WO2007016792A1 Orf11 from campylobacter jejuni is a sialate-o-acetyltransferase |
| 02/15/2007 | WO2007016777A1 Targeted protein kinase c inhibitors and uses thereof |
| 02/15/2007 | WO2007016763A1 Peptides targeted to protein kinase c isoforms and uses thereof |
| 02/15/2007 | WO2006124678A3 Corn plants and seed enhanced for asparagine and protein |
| 02/15/2007 | WO2006109198A3 Methods for obtaining optically active glycidyl ethers and optically active vicinal diols from racemic substrates |
| 02/15/2007 | WO2006076742A3 Methods and compositions for increasing membrane permeability |
| 02/15/2007 | WO2006012518A3 METHOD AND COMPOSITIONS INVOLVING PROTEIN KINASE-δ |
| 02/15/2007 | WO2005100582A3 Methods for degrading or converting plant cell wall polysaccharides |
| 02/15/2007 | WO2005056570A3 Production of amino sugars |
| 02/15/2007 | WO2005003289A8 Ap1 amine oxidase variants |
| 02/15/2007 | WO2004023270A8 Crystal structure of angiotensin-converting enzyme-related carboxypeptidase |
| 02/15/2007 | US20070039070 transforming plant cells with a DNA construct comprising nucleic acid sequences, Eucalyptus caffeic acid 3-O-methyltransferase (COMT) promoters and nucleic acid sequence that code for polypeptides, then culturing said transformed plant cells, to producing transgenic plants |
| 02/15/2007 | US20070039064 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
| 02/15/2007 | US20070039063 Trangenic diploid cell comprising mutation in kinase allele for use in screening modulator for treatment of anxiety, addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures and epilepsy |
| 02/15/2007 | US20070038380 Crystal structure of E.coli GDP-fucose synthetase (and complexes thereof) and methods of identifying agonists and antagonists using same |
| 02/15/2007 | US20070037967 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 02/15/2007 | US20070037870 Novel substance having alpha-glucosidase inhibiting activity and food containing the same |
| 02/15/2007 | US20070037746 Novel compounds |
| 02/15/2007 | US20070037270 Method for the purification of alpha-1 proteinase inhibitor (a1PI) |
| 02/15/2007 | US20070037269 Mutants of desoxycytidine kinase having extended enzymatic activity |
| 02/15/2007 | US20070037264 Using trangenic microorganism having nitrilase and amidase activities to convert (E,Z)-2-methyl-2-butenenitrile into (E and Z)-2-methyl-2-butenoic acids |
| 02/15/2007 | US20070037263 Novel acetoacetyl-coa reductase and process for producing optically active alcohol |
| 02/15/2007 | US20070037262 Genes encoding genetic stability, gene expression and folding proteins |
| 02/15/2007 | US20070037261 Genes encoding carbon metabolism and energy-producing proteins |
| 02/15/2007 | US20070037254 Expression Vectors and Methods |
| 02/15/2007 | US20070037251 Novel protein expression system |
| 02/15/2007 | US20070037250 Method for obtaining precursor Z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency |
| 02/15/2007 | US20070037247 Polypeptide having a thermostable ribonuclease H activity; highly valuable for genetic engineering |
| 02/15/2007 | US20070037246 Methods and compositions for enhanced protein expression and purification |
| 02/15/2007 | US20070037190 DNA ligase mutants |
| 02/15/2007 | US20070037159 Tetrahydrofolate synthetase gene |
| 02/15/2007 | US20070037150 Tyrosine kinome |
| 02/15/2007 | US20070037141 comprise DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells |
| 02/15/2007 | US20070036883 Plant-derived alkaline alpha-galactosidase |
| 02/15/2007 | US20070036872 Alpha-glucosidase activity inhibitor |
| 02/15/2007 | US20070036841 Method of enhancing an ornithine-urea cycle in ruminant gut tissues to detoxify ammonia and increase local urea recycling to the rumen for microbial protein synthesis |
| 02/15/2007 | US20070036822 Selection system containing non-antibiotic resistance selection marker |
| 02/15/2007 | US20070036814 Antibody binding to polypeptide of given sequence; antisera; use in wound healing, blocking adherence to indwelling medical devices, vaccines |
| 02/15/2007 | US20070036793 Methods for use of an lkb1/strad7mo25 complex |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036721 Methods and compositions for in vivo inflammation monitoring |
| 02/15/2007 | CA2659961A1 Targeted protein kinase c inhibitors and uses thereof |
| 02/15/2007 | CA2659958A1 Peptides targeted to protein kinase c isoforms and uses thereof |
| 02/15/2007 | CA2625933A1 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 02/15/2007 | CA2618779A1 Phosphoadenylyl sulfate reductase gene and use thereof |
| 02/15/2007 | CA2618769A1 Orf11 from campylobacter jejuni is a sialate-o-acetyltransferase |
| 02/15/2007 | CA2617714A1 Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants |
| 02/15/2007 | CA2615305A1 Extracellular polyhydroxyalkanoates produced by genetically engineered microorganisms |
| 02/14/2007 | EP1752769A1 Composition for measuring glucose having improved substrate specificity |
| 02/14/2007 | EP1752539A2 cDNA for human methylenetetrahydrofolate reductase |
| 02/14/2007 | EP1752538A1 Human bikunin |
| 02/14/2007 | EP1752537A1 9-fatty acid hydroperoxide lyase genes |
| 02/14/2007 | EP1752534A1 High-speed pcr using high-speed dna polymerase |
| 02/14/2007 | EP1752533A1 Fusion proteins between plant cell-wall degrading enzymes, and their uses |
| 02/14/2007 | EP1752532A1 Extracellular polyhydroxyalkanoates produced by genetically engineered microorganisms |
| 02/14/2007 | EP1752531A1 Method for improving substrate specificity of pyrroloquinoline quinone dependent glucose dehydrogenase |
| 02/14/2007 | EP1752530A1 Composition for suppression PQQGDH reaction inhibition |
| 02/14/2007 | EP1752525A1 Amylase variants |
| 02/14/2007 | EP1752160A2 Epitope sequences |
| 02/14/2007 | EP1751305A2 Method of selecting sunflower genotypes with high oleic acid content in seed oil |
| 02/14/2007 | EP1751293A1 Process for an enzymatic oxygenation by direct electrochemical regeneration of the fad-dependant monooxygenase |
| 02/14/2007 | EP1751292A1 A method to produce succinic acid from raw hydrolysates |
| 02/14/2007 | EP1751287A2 Improved 2-deoxy-d-ribose 5-phosphate aldolases (deras) and the uses thereof |
| 02/14/2007 | EP1751286A2 Biosynthetic gene cluster for the production of a complex polyketide |
| 02/14/2007 | EP1751283A1 Fed-batch fermentation process and culture medium for the production of plasmid dna in e.coli on a manufacturing scale |
| 02/14/2007 | EP1751281A2 Aspergillus kawachi acid-stable alpha amylase and applications in granular starch hydrolysis |
| 02/14/2007 | EP1751280A2 Tobacco nicotine demethylase genomic clone and uses thereof |
| 02/14/2007 | EP1751279A2 Nucleic acids and polypeptides involved in the production of cryptophycin |
| 02/14/2007 | EP1751278A2 Nicotiana nucleic acid molecules and uses thereof |
| 02/14/2007 | EP1751277A2 Method for identifying compounds that have the ability to inhibit the activity of myc |
| 02/14/2007 | EP1751270A1 Self-containing lactobacillus strain |
| 02/14/2007 | EP1751180A2 Enzymes, cells and methods for site specific recombination at asymmetric sites |
| 02/14/2007 | EP1750760A1 Preservation by vaporization |
| 02/14/2007 | EP1750757A2 Methods of purifying chondroitinase and stable formulations thereof |
| 02/14/2007 | EP1581253A4 Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents |
| 02/14/2007 | EP1546318A4 Microbial trypsin variants having chymotrypsin activity and nucleic acids encoding same |
| 02/14/2007 | EP1456363B1 Alleles of the siga gene from coryneform bacteria |
| 02/14/2007 | EP1360283B1 Expression of recombinant proteinase k from tritirachium album in yeast |
| 02/14/2007 | EP1347048B1 Novel protease |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1343876B1 Modulators of activity of g-protein-coupled receptor kinases |
| 02/14/2007 | EP1328645B1 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 02/14/2007 | EP1206495B1 Chimeric polypeptides, method for production and uses thereof |
| 02/14/2007 | EP1156106B1 Ezyme having decoloring activity and method for decoloring dyes by using the same |
| 02/14/2007 | EP1147174B1 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids |
| 02/14/2007 | EP0977875B1 Improved prokaryotic expression of protein |
| 02/14/2007 | EP0871713B1 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
| 02/14/2007 | EP0827543B1 Production of 1,3-propanediol from glycerol by recombinant bacteria expressing recombinant diol dehydratase |
| 02/14/2007 | EP0820283B1 Lactacystin analogs |
| 02/14/2007 | EP0815200B1 Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production |
| 02/14/2007 | EP0770136B1 Method for selecting high-expressing host cells |
| 02/14/2007 | CN1914328A L-thereonine producing bacterium belonging to the genus escherichia and method for producing l-threonine |
| 02/14/2007 | CN1914316A Stabilization of enzymes |
| 02/14/2007 | CN1914315A Protein with activity of hydrolyzing dextran, starch, mutan, inulin and levan, gene encoding the same, cell expressing the same, and production method thereof |
| 02/14/2007 | CN1914311A Methods for eliminating or reducing the expression of a genes in a filamentous fungal strains |
| 02/14/2007 | CN1913880A Method for treating ADAMTS-5-associated disease |
| 02/14/2007 | CN1913785A Stabilized enzyme formulations |
| 02/14/2007 | CN1913774A Disease model animal expressing MEGSIN/RAGE/iNOS and method of evaluating compound with the use of the animal |
| 02/14/2007 | CN1912119A Human HS5 AR-iso gene sequence, its coded protein and preparation method |
| 02/14/2007 | CN1912118A Materials and methods for the alteration of enzyme and acetyl coa levels in plants |